Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MenSCs versus PRP for thin nonfunctional endometrium in infertile women
IRCT20180619040147N3Phase 2Completed
- Sponsor
- ACECR
- Start
- May 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous menstrual blood-derived stem cells and platelet-rich plasma in Endometrial hypotrophy and female infertility (2 arms), sponsored by ACECR. Primary endpoints: Endometrial thickness, Uterine arterial blood flow and 6 more. Started May 2020; status: completed.
02
Drugs
autologous menstrual blood-derived stem cellsplatelet-rich plasma
03
Conditions
Endometrial hypotrophyfemale infertility
Beyond the preview
Go deeper on IRCT20180619040147N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180619040147N3.